Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-21

Clinical Trial Update: Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir) [NA]

View source ↗

Summary

A pharmacokinetic study evaluating interactions between buprenorphine and Kaletra (lopinavir/ritonavir) in HIV infection; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kaletra (lopinavir)
  • buprenorphine (buprenorphine)

Snippet

Sponsor: Yale University | Conditions: HIV Infections | NA | Status: COMPLETED | Results posted: 2012-11-21